https://www.selleckchem.com/pr....oducts/Vorinostat-sa
Further studies are warranted to identify the mechanism of the prebiotics-gut-bone axis.Studies show that patients with elevated triglycerides and well-controlled LDL levels under statin therapy still have a significant residual risk of cardiovascular (CV) events. Despite many attempts to reduce triglycerides with different hypolipidemic drugs, no therapeutic option has given satisfactory results so far. The initial enthusiasm that omega-3 fatty acids can effectively reduce triglycerides and CV risk was replaced with skepticism
Like
Comment
Share
